Evidence map›Paper›PMID 39687966›Full record

ArticleHuman vaccines & immunotherapeutics2024

Gathering information on maternal immunization readiness in Bangladesh, Ghana, Kenya, Mozambique, and Nepal: Applying a WHO checklist.

Ranju Baral, Sophia Knudson, Iracema Barros, Patience Cofie, Patience Dapaah, Sadaf Khan, Sandeep Kumar, Kamran Mehedi, Lauren Newhouse, Elkanah Otiang and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ranju BaralCenter for Vaccine Innovation and Access, PATH, Seattle, USA.ORCID 0000-0002-3043-6070
Sophia KnudsonPrimary Health Care, PATH, Seattle, USA.
Iracema BarrosPrimary Health Care, PATH, Maputo, Mozambique.
Patience CofiePrimary Health Care, PATH, Accra, Ghana.
Patience DapaahMedical Devices and Health Technologies, PATH, Accra, Ghana.
Sadaf KhanPrimary Health Care, PATH, Seattle, USA.
Sandeep KumarIndia Country Program, PATH, New Delhi, India.
Kamran MehediCenter for Vaccine Innovation and Access, PATH, Dhaka, Bangladesh.
Lauren NewhouseCenter for Vaccine Innovation and Access, PATH, Seattle, USA.
Elkanah OtiangEpidemic Preparedness and Response, PATH, Nairobi, Kenya.
Rosemond OwusuIndependent Consultant, Accra, Ghana.
Clint PecenkaCenter for Vaccine Innovation and Access, PATH, Seattle, USA.
Melanie PicoloPrimary Health Care, PATH, Maputo, Mozambique.
Judite PintoPrimary Health Care, PATH, Maputo, Mozambique.
Diana QuelhasIndependent Consultant, Maputo, Mozambique.
Satyabrata RoutrayIndia Country Program, PATH, New Delhi, India.
Surendra UranwB.P. Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Jessica A FlemingCenter for Vaccine Innovation and Access, PATH, Seattle, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New respiratory syncytial virus (RSV) maternal vaccines have begun roll out in some countries, with efforts in progress to broaden access worldwide and shorten the timeline to access for low- and middle-income countries (LMICs). Prior to new maternal immunization (MI) introductions, countries will need to evaluate their capacity and readiness for successful introduction. The World Health Organization's Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) project (2016-2019) developed a checklist for countries to self-evaluate their capacity to introduce new maternal vaccines. Here, we report on our use of the MIACSA checklist in Bangladesh, Ghana, Kenya, Mozambique, and Nepal to gather country stakeholders' perceptions of MI readiness and provide additional considerations for implementers when using the checklist to optimize its usefulness.

Indexed as

ChecklistWorld Health OrganizationBangladeshDeveloping CountriesFemaleGhanaHumansImmunizationImmunization ProgramsKenyaMozambiqueNepalPregnancyPrenatal CareRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus Vaccineschecklistcountry readinessMaternal vaccines

Identifiers

PMID39687966
PMCPMC11654705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.